141
- EPOCAL turning point in Alzheimer’s: Donanemab is a revolution Microbiology Italy
- Healthcare, here is the experimental drug that slows down Alzheimer’s The print
- Donanemab for Alzheimer’s: the drug seems to slow the progression of the disease, but can cause serious side effects WIRED Italia
- Alzheimer’s, a new drug slows the decline / Delayed the worsening by 35% Il Sussidiario.net
- See full coverage on Google News